SMI Equal Weight

SMI Equal Weight handeln
378,16 PKT -2,78 PKT -0,73 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

ISIN CH1528602787


Analysen zu SMI Equal Weight-Werten

Datum Rating Analyst
13.04.11 UBS equal-weight Morgan Stanley
13.04.11 Novartis buy Vontobel Research
13.04.11 Kühne + Nagel International hold Vontobel Research
13.04.11 Holcim neutral Exane-BNP Paribas SA
12.04.11 Sika buy Vontobel Research
11.04.11 Novartis buy Vontobel Research
08.04.11 Nestlé halten Independent Research GmbH
07.04.11 Novartis buy Vontobel Research
04.04.11 Zurich Insurance halten Independent Research GmbH
04.04.11 Swiss Life buy Vontobel Research
04.04.11 Swisscom hold UniCredit Research
01.04.11 Novartis buy Vontobel Research
01.04.11 Logitech buy Vontobel Research
01.04.11 Zurich Insurance buy Nomura
31.03.11 Zurich Insurance buy Vontobel Research
30.03.11 Novartis buy Nomura
30.03.11 ABB (Asea Brown Boveri) sell UniCredit Research
29.03.11 Geberit halten Öko Invest
29.03.11 Novartis kaufen Hamburger Sparkasse AG (Haspa)
29.03.11 Novartis buy Société Générale Group S.A. (SG)
29.03.11 Lonza hold Vontobel Research
28.03.11 Novartis kaufen Independent Research GmbH
24.03.11 UBS overweight Morgan Stanley
23.03.11 Novartis buy Vontobel Research
22.03.11 ABB (Asea Brown Boveri) kaufen Hamburger Sparkasse AG (Haspa)
22.03.11 Kühne + Nagel International hold Vontobel Research
22.03.11 Zurich Insurance buy Société Générale Group S.A. (SG)
25.03.11 Nestlé neutral J.P. Morgan Cazenove
21.03.11 Sika buy Vontobel Research
16.03.11 Novartis buy UBS AG
16.03.11 Kühne + Nagel International equal-weight Morgan Stanley
15.03.11 Partners Group hold Vontobel Research
15.03.11 Novartis buy Vontobel Research
14.03.11 Partners Group hold Vontobel Research
11.03.11 Geberit hold Vontobel Research
11.03.11 Swiss Life kaufen Der Aktionär
10.03.11 Geberit hold Vontobel Research
10.03.11 Swiss Life buy Vontobel Research
10.03.11 Novartis buy UBS AG
09.03.11 Novartis buy Vontobel Research